Boehringer Ingelheim Symposium

Date: Thursday 29 September 2022
Time: 13:15–14:30 CET

Duration: 75 min

Title: Exploring a New Path Forward in Generalized Pustular Psoriasis

Objectives:

– Describe the clinical features and disease burden of GPP flares for patients
– Appreciate that GPP is a distinct clinical entity from plaque psoriasis
– Review the evidence highlighting the central role of IL-36 in GPP
– Discuss the unmet needs in GPP treatment, and present targeted GPP-specific treatments in development

 

Chair – Peter van de Kerkhof
  • Speakers: Mahira El Sayed, Abby Van Voorhees, Johann Gudjonsson
 

PROGRAM

 

 

13.15–13.20

Welcome and Introductions

Peter van de Kerkhof (The Netherlands)

 

13.20–13-35

Rough Terrain: Current Challenges with GPP Flares

Mahira El Sayed (Egypt)

 

13.35–13.50

A Fork in the Road: Distinguishing GPP from Plaque Psoriasis

Abby Van Voorhees (United States)

 

13.50–14.05

IL-36: Exploring a Central Pathway in GPP

Johann Gudjonsson (United States)

 

14.05–14.20

Forging a New Path in GPP: From Bench to Bedside

Peter van de Kerkhof (The Netherlands)

 

14.20–14.30

Q&A and Closing Remarks

All Above Speakers